Organization: Health Canada
Year: 2022
Month: August
Request Number: A-2022-000280
Request Summary: Adverse Drug Reactions (ADRs) for Mesalazine. Report numbers: E2B_05100649, E2B_05185665, E2B_05096839. ADR for Mesalamine. Report number: E2B_05090601. ADR for C1 Esterase Inhibitor (Human). Report number: E2B_05098849. ADRs for Immunoglobulin (human). Report numbers: E2B_05105803, E2B_05094877, E2B_05196831. ADR for Antihemophilic factor (human). Report number: E2B_05162608.
Disposition: Disclosed in part
Number of pages: 403